Your browser doesn't support javascript.
loading
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP).
Raez, Luis E; Arrieta, Oscar; Chamorro, Diego F; Soberanis-Piña, Pamela Denisse; Corrales, Luis; Martín, Claudio; Cuello, Mauricio; Samtani, Suraj; Recondo, Gonzalo; Mas, Luis; Zatarain-Barrón, Zyanya Lucia; Ruíz-Patiño, Alejandro; García-Robledo, Juan Esteban; Ordoñez-Reyes, Camila; Jaller, Elvira; Dickson, Franco; Rojas, Leonardo; Rolfo, Christian; Rosell, Rafael; Cardona, Andrés F.
Afiliação
  • Raez LE; Thoracic Oncology Program, Memorial Cancer Institute, Florida Atlantic University (FAU), Miami, FL, United States.
  • Arrieta O; Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), Mexico City, Mexico.
  • Chamorro DF; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Soberanis-Piña PD; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia.
  • Corrales L; Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), Mexico City, Mexico.
  • Martín C; Thoracic Oncology Unit, Centro de Investigación y Manejo del Cáncer - CIMCA, San José, Costa Rica.
  • Cuello M; Thoracic Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina.
  • Samtani S; Medical Oncology Department, Hospital de Clínicas, Universidad de la Republica - UdeLAR, Montevideo, Uruguay.
  • Recondo G; Medical Oncology Department, Clinica Las Condes, Santiago, Chile.
  • Mas L; Thoracic Oncology Unit, Centro de Educación Médica e Investigaciones Clinicas (CEMIC), Buenos Aires, Argentina.
  • Zatarain-Barrón ZL; Medical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas - INEN, Lima, Peru.
  • Ruíz-Patiño A; Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), Mexico City, Mexico.
  • García-Robledo JE; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Ordoñez-Reyes C; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia.
  • Jaller E; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ, United States.
  • Dickson F; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Rojas L; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia.
  • Rolfo C; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Rosell R; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia.
  • Cardona AF; Thoracic Oncology Program, Memorial Cancer Institute, Florida Atlantic University (FAU), Miami, FL, United States.
Front Oncol ; 12: 904800, 2022.
Article em En | MEDLINE | ID: mdl-35903685
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article